"Cost-Benefit Analysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. Cost effectiveness compares alternative ways to achieve a specific set of results.
| Descriptor ID |
D003362
|
| MeSH Number(s) |
N03.219.151.125
|
| Concept/Terms |
Cost-Benefit Analysis- Cost-Benefit Analysis
- Analyses, Cost-Benefit
- Analysis, Cost-Benefit
- Cost-Benefit Analyses
- Cost Benefit Analysis
- Analyses, Cost Benefit
- Analysis, Cost Benefit
- Cost Benefit Analyses
Cost-Utility Analysis- Cost-Utility Analysis
- Analyses, Cost-Utility
- Analysis, Cost-Utility
- Cost Utility Analysis
- Cost-Utility Analyses
Economic Evaluation- Economic Evaluation
- Economic Evaluations
- Evaluation, Economic
- Evaluations, Economic
Marginal Analysis- Marginal Analysis
- Analyses, Marginal
- Analysis, Marginal
- Marginal Analyses
Cost Benefit- Cost Benefit
- Costs and Benefits
- Benefits and Costs
|
Below are MeSH descriptors whose meaning is more general than "Cost-Benefit Analysis".
Below are MeSH descriptors whose meaning is more specific than "Cost-Benefit Analysis".
This graph shows the total number of publications written about "Cost-Benefit Analysis" by people in this website by year, and whether "Cost-Benefit Analysis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 0 | 4 | 4 |
| 2004 | 0 | 3 | 3 |
| 2005 | 0 | 4 | 4 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 8 | 8 |
| 2008 | 1 | 5 | 6 |
| 2009 | 0 | 3 | 3 |
| 2010 | 0 | 7 | 7 |
| 2011 | 0 | 8 | 8 |
| 2012 | 0 | 11 | 11 |
| 2013 | 0 | 10 | 10 |
| 2014 | 2 | 5 | 7 |
| 2015 | 1 | 6 | 7 |
| 2016 | 3 | 21 | 24 |
| 2017 | 70 | 201 | 271 |
| 2018 | 76 | 192 | 268 |
| 2019 | 22 | 68 | 90 |
| 2020 | 3 | 24 | 27 |
| 2021 | 3 | 29 | 32 |
To return to the timeline, click here.
Below are the most recent publications written about "Cost-Benefit Analysis" by people in Profiles.
-
Cost-effectiveness of Tocilizumab in Severe Coronavirus Disease 2019: to See or Not to See. Clin Infect Dis. 2021 12 06; 73(11):2119-2120.
-
Combination Therapy With Tocilizumab and Dexamethasone Cost-Effectively Reduces Coronavirus Disease 2019 Mortality. Clin Infect Dis. 2021 12 06; 73(11):2116-2118.
-
Lives and Costs Saved by Expanding and Expediting Coronavirus Disease 2019 Vaccination. J Infect Dis. 2021 09 17; 224(6):938-948.
-
The EPIPHA-KNEE trial: Explaining Pain to target unhelpful pain beliefs to Increase PHysical Activity in KNEE osteoarthritis - a protocol for a multicentre, randomised controlled trial with clinical- and cost-effectiveness analysis. BMC Musculoskelet Disord. 2021 Aug 28; 22(1):738.
-
Data driven high resolution modeling and spatial analyses of the COVID-19 pandemic in Germany. PLoS One. 2021; 16(8):e0254660.
-
Preliminary model assessing the cost-effectiveness of preoperative chlorhexidine mouthwash at reducing postoperative pneumonia among abdominal surgery patients in South Africa. PLoS One. 2021; 16(8):e0254698.
-
Cost-Effectiveness Analysis of Remdesivir Treatment in COVID-19 Patients Requiring Low-Flow Oxygen Therapy: Payer Perspective in Turkey. Adv Ther. 2021 09; 38(9):4935-4948.
-
Cost-effectiveness of bariatric and metabolic surgery, and implications of COVID-19 in the United Kingdom. Surg Obes Relat Dis. 2021 11; 17(11):1897-1904.
-
Role of bariatric surgery in a COVID-19 era: a review of economic costs. Surg Obes Relat Dis. 2021 12; 17(12):2091-2096.
-
Development of rapid and cost-effective top-loading device for the detection of anti-SARS-CoV-2 IgG/IgM antibodies. Sci Rep. 2021 07 21; 11(1):14926.